하민진 교수 보건대학원
전공
생물통계학
연구실
종합관 324
전화/팩스
02-2228-1529 / 02-392-7734
소개
- 학력
-
- University of North Carolina- Chapel Hill (박사)
- 경력
-
- 2013.10-2016.04 텍사스주립대 MD Anderson Cancer Center 박사후 연구원
- 2016.05-2022.02 텍사스주립대 MD Anderson Cancer Center 조교수
- 2016.05-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences 조교수
- 2022.03- 연세대학교 보건대학원 보건정보통계학과 조교수 (전공지도교수)
- 학술활동
-
- 2023.04-2025.03 건강보험심사평가원 객원연구위원
- 2022.09-2027.02 한국연구재단 중견연구 연구책임자 (다층 데이터를 위한 그래프 이론 기반 융합적 통계 방법론 연구)
- 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Quantitative Sciences curriculum committee 자문위원
- 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Faculty Academic Review Committee, 자문위원
- 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Department of Biostatistics, Faculty Search committee, 자문위원
- 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Institutional Animal Care and Use Committee, 자문위원
- 2016.05-2017.12 공동연구자, 미국국립보건원
- (Title: Risk Prediction for ER-Negative Breast Cancer Recurrence)
- 2016.05-2020.11 공동연구자, 미국국립보건원
- (Title: Graph-based Bayesian Analysis of Genomics and Proteomics Data)
- 2016.08-2020.08 공동연구자, Cancer Prevention & Research Institute of Texas
- (Title: Acute Myeloid Leukemia in the Immunosuppressed Microenvironment)
- 2016.08-2021.08 공동연구자, Cancer Prevention & Research Institute of Texas
- (Title: A Randomized Clinical Trial Platform)
- 2017.09-2021.08 공동연구자, 미국국립보건원
- (Title: Cytoplasmic cyclin E is an early event for progression inva- sive breast cancer)
- 2018.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas
- (Title: Overcoming PARP inhibitor resistance in pa- tients with breast cancer who have germline BRCA mutations)
- 2020.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas, 미국
- (Title: Targeted Proteolysis of Glucocorticoid Receptor (GR) as a Therapeutic Strategy to Enhance Anti-Tumor Immunity)
- 2019.10-2022.09 공동연구자, 미국국립보건원
- (Title: Mechanisms and Vulnerabilities of SWI/SNF chromatin remod- eling complex mutant lung cancer)
- 2016.08-2022.02 공동연구자, 미국국립보건원
- (Title: SPORE: Targeting Lung Cancer Vulnerabilities)
- 2018.08-2022.08 공동연구자, Cancer Prevention & Research Institute of Texas, 미국
- (Title: Rational Combination Treatment Options to Reverse Resistance in Hormone Receptor Positive
- Breast Cancer Refractory to Standard Therapy)
- 2019.09-2022.02 공동연구자, The University of Texas MD Anderson Cancer Center
- (Title: Therapeutic Targeting of DKK3 in Pancreatic Cancer and Response to Chemotherapy)
- 2021.07-2022.02 공동연구자, 미국국립보건원
- (Title: RNase H2 is a novel therapeutic target in triple negative breast cancer)
- 2021.07-2022.02 공동연구자, Boehringer Ingelheim Pharm Inc
- (Title: Targeting ROR1 Overexpressing Tumors with NBE-002)
- 2016.09-2022.02 Biostatistician, Biostatistics Resource Group, 텍사스주립대 MD Anderson Cancer Center
- 2016.09-2017.08 Biostatistician, Department of Breast Surgical Oncology, 텍사스주립대 MD Anderson Cancer Center
- 2018.09-2022.02 디렉터, Biostatistics and Bioinformatics, Leukemia and Lymphoma Society, 미국
- 2019.10-2022.02 디렉터, Data Science, 미국국립보건원 (University of Texas PDX Development and Trial Center)
- 2018.07-2021.06 연구책임자, 미국국립보건원
- (Title: Proteomic-based integrated subject-specific networks in cancer)
- 2021.02-2022.02 연구책임자, 미국국립보건원
- (Title: Bayesian Network-Based Integrative Ge- nomics Methods for Precision Medicine)
- 연구분야
-
- Graphical Models
- Bayesian Statistics
- Causal Mediation Analysis
- Machine Learning
- High-dimensional Statistics
- Omic Data